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Kisspeptin Modulates Luteinizing
Hormone Release and Ovarian
Follicular Dynamics in Pre-pubertal
and Adult Murrah Buffaloes
Vishalkumar Pottapenjera 1 , Srinivasa R. Rajanala 2 , Chandrasekhar Reddy 1 ,
Arunakumari Gangineni 1*, Kiran Avula 2 , Sandeep K. Bejjanki 1 , Sriravali Sathagopam 2 ,
Surabhi Kesharwani 1 and Sathya Velmurugan 2*†
1

Department of Veterinary Gynaecology and Obstetrics, College of Veterinary Science, PV Narasimha Rao Telangana
Veterinary University, Hyderabad, India, 2 National Institute of Animal Biotechnology, Hyderabad, India

Kisspeptin is a neuropeptide that governs the reproductive axis upstream to GnRH.
We wanted to study whether kisspeptin modulates plasma LH and FSH levels and
ovarian follicular dynamics in buffaloes and whether kisspeptin can be used for fixed
time artificial insemination (FTAI). We carried out these studies in comparison with
buserelin, a potent GnRH agonist. Kisspeptin dose-dependently increased plasma LH
levels. However, the kisspeptin-induced increase in LH was short-lived as the peak
reached in 15–30 min returned to basal values by 1–2 h. The kisspeptin-induced increase
in LH level was less compared to buserelin-induced increase in LH level which sustained
over time. Kisspeptin did not enhance FSH release while buserelin resulted in a gradual
increase over time. LH response to repeated injections of kisspeptin was greater
than that induced by buserelin. While buserelin induced an increase in the number of
follicles, kisspeptin induced an increase in the growth rate of the follicle. In adult cycling
animals, while both the drugs increased plasma LH levels, the increase was greater in
buserelin group compared to kisspeptin group. In contrast to the findings in pre-pubertal
animals, kisspeptin induced an increase in both the number as well as the size of
follicles compared to buserelin. Our studies on oestrus synchronization, using either
kisspeptin-PGF2α -kisspeptin protocol or buserelin-PGF2α -buserelin Ovsynch protocol on
day 0, 7, and 9, respectively, revealed that kisspeptin increased the number of follicles at
wave emergence and the diameter of dominant follicle after 2nd dose of drug, the oestrus
response rate and duration of oestrus, compared to buserelin. However, conception rate
was not significantly different among the groups. From our studies, it appears that Kp
and Buserelin differentially modulate follicular dynamics depending on the reproductive
age of the animals.However, studies in a larger herd are required to confirm whether
kisspeptin can be used for oestrous synchronization in buffaloes.
Keywords: kisspeptin, buserelin, Murrah buffaloes, LH, FSH, follicular dynamics, oestrous synchronization
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INTRODUCTION

Twelve multiparous cycling non-pregnant lactating Murrah
buffaloes, aged between 4 and 10 years, all in their mid-lactation,
with parity ranging from 2 to 5, from the Farm Complex, were
used for studies in adult buffaloes. All the animals were clinically
normal and had regular oestrous cycles. During the experimental
period (i.e., August to February; autumn and winter), these adult
buffaloes were maintained under semi-intensive housing system
and were fed with green fodder, concentrate feed, and ad-libitum
drinking water.

Kisspeptin is one of the controllers of hypothalamo-pituitarygonadal (HPG) axis upstream to gonadotropin releasing
hormone (GnRH). Neuroendocrine control of GnRH neurons by
kisspeptin orchestrates the sequences that take place during the
oestrous cycle (1). In the hypothalamus, kisspeptin is expressed
in the arcuate nucleus and rostral periventricular region in
rats and in the arcuate nucleus and preoptic area in sheep
(2, 3). Apart from hypothalamus, expressionof Kiss1 gene and
immunoreactivity of kisspeptin and its receptor, GPR54, have
been reported in extra-hypothalamic tissues, such as ovaries, in
rats and sheep (4).
Currently, GnRH or luteinizing hormone (LH) are being
used to induce ovulation, via oestrus synchronization protocol,
in subfertile buffaloes. However, the conception rate is only
50–55% in a synchronization protocol that uses GnRH and
prostaglandin (5). Hence, new therapeutic strategies aiming
at increased conception rate and reduced fertility disorders
are warranted. Studying the endocrine profile and follicular
dynamics upon kisspeptin administration would be a key step
toward kisspeptin-based therapeutic strategies.
Induction of LH secretion by kisspeptin administration has
been reported in steer, pre-pubertal calves and ovariectomized
cows (6). In buffaloes, intramuscular injection of kisspeptin has
been shown to induce LH secretion in both breeding and nonbreeding seasons (7). Though kisspeptin has been proposed as a
regulator of ovulation at the ovarian level, the effect of kisspeptin
on the follicular dynamics as a whole has not been studied
yet. In order to address this, we studied the endocrine profile
and follicular dynamics upon kisspeptin administration in prepubertal and adult buffaloes with the specific hypothesis that
kisspeptin regulates follicular dynamics in buffaloes. We also
report our findings on oestrus synchronization in buffaloes when
kisspeptin is used instead of buserelin, a potent GnRH agonist.

Drugs
Bovine kisspeptin (Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-TyrNH2), a decapeptide, was commercially synthesized (Biotech
Desk). Stock solutions were prepared at the concentration
of 5 mg/ml in distilled water and aliquots were frozen at
−20◦ C until use. Stocks were diluted in normal saline to a
working solution of 2.5 ml volume. Buserelin acetate (Receptal
Vet; Intervet India—MSD Animal Health) was commercially
obtained. Each ml of the commercial preparation contained 4.2
µg of buserelin acetate equivalent to 4.0 µg of buserelin. Drugs
were administered either intramuscularly (IM) or intravenously
(IV). We chose 10 µg/animal as the dose rate for buserelin as
recommended by the manufacturer for delayed ovulation and
anovulation. For kisspeptin, we used doses starting from 5 µg/kg
as this has been shown to significantly increase plasma LH in
cattle (8).

ELISA
Plasma LH and FSH concentrations were quantified using bovine
ELISA kits (Abnova; Catalogue No. KA2280 and KA2278) as per
the manufacturer’s instructions. The limits of detection were 0.25
and 0.5 ng/ml, respectively, for LH and FSH. The samples were
analyzed in duplicates. The inter-assay coefficient of variability
(CV) was less than 12.5% and the intra-assay CV was less than
7.5%.

Studies in Pre-pubertal Buffaloes
Dose-Response Study

MATERIALS AND METHODS

In pre-pubertal buffaloes, dose-response studies on the effect
of kisspeptin (bolus injections at 5, 10, and 20 µg/kg body
weight; or 3.85, 7.7, and 15.4 nmol/kg body weight; 2.5 ml;
IM and IV) on plasma LH concentration was carried out
(n = 6; kisspeptin group). In another group (n = 5; buserelin
group), LH profiles following administration of buserelin at the
recommended dosage (10 µg/animal, 2.5 ml, IM and IV) were
studied for comparison. Plasma follicle stimulating hormone
(FSH) was also estimated upon administration of buserelin and
the maximal dose of kisspeptin (i.e., 20 µg/kg). In kisspeptin
group, following initial basal observation of follicular dynamics
for a week, kisspeptin was administered at the above doses at
weekly intervals, i.e., each dose was administered at regular
interval in such a way that a minimum of 4 ultrasound
observations of follicular dynamics could be carried out on
alternate days. The methodology is schematically given in
Figure 1. On the day of administration of drugs, the buffaloes
were fitted with intravenous cannula in jugular vein enabling
sequential sampling. The time points of sampling following IM

Experimental Animals
All animals were maintained at the Department of Instructional
Livestock Farm Complex, College of Veterinary Science, PV
Narasimha Rao Telangana Veterinary University (PVNR TVU),
Hyderabad, India. The experiments were approved by the
Institutional Animal Ethics Committee of College of Veterinary
Science, PVNR TVU.
Six pre-pubertal Murrah buffaloes, procured from Yeluru
village in Medak district, Telangana, and five pre-pubertal
Murrah buffaloes, born at the Farm Complex, were quarantined
for 2 weeks and acclimatized for experimental sheds. These
animals weighed 200–250 kg and were between 1 and 1.5 years
of age, approximately. Throughout the experimental period (i.e.,
March to May; summer), the heifers were maintained as a group
and were housed using semi-intensive system, which included a
covered shed and an open paddock, under identical conditions
of concentrate and roughage feeding and other managemental
practices.
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at wave emergence represents the number of follicles observed
on the day of wave emergence which occurs after the dominant
follicle of the previous wave starts to become atretic. The smallest
diameter considered for identification of follicles was 2 mm.
Follicles were categorized as small (<5 mm), medium (5–8 mm)
and large follicles [>9 mm; (9)]. Growth rate was calculated for
all the growing follicles. Before beginning any of the experiments,
follicular dynamics was studied for a duration of 10 days without
administration of any drug and this was regarded as the control
period. Ovulation was not observed in any of the pre-pubertal
heifers during the entire period of the study.

Studies in Adult Buffaloes

FIGURE 1 | Schematic representation of methodology for
dose-response study. Following initial basal observation of follicular dynamics
for a week, kisspeptin was administered at three different doses at two routes
(i.e., IM or IV) at weekly intervals approximately. A minimum of 4 ultrasound
observations of follicular dynamics were carried out on alternate days between
two injections, as depicted by the solid black arrow. Buserelin was
administered at a single dose rate recommended by the manufacturer via two
routes (i.e., IM or IV) at triweekly intervals approximately, as depicted by the
longer white arrows.

Effect of Kisspeptin vs. Buserelin on Plasma LH and
FSH and on Follicular Dynamics
During a preliminary study, ultrasound examinations were
carried out daily for two consecutive oestrous cycles to know
the follicular wave pattern in all experimental animals (n = 12).
It was observed that out of 12 buffaloes 10 showed two-wave
pattern and two buffaloes showed three-wave pattern. After
ascertaining the follicular wave pattern, experimental buffaloes
were randomly divided into two groups and administered either
kisspeptin (20 µg/kg, IV; n = 6) or buserelin (10 µg, IV; n = 6)
on 11th or 8th day of estrous cycle depending on whether the
oestrous cycle is of two-wave or three-wave pattern, respectively,
correlating with emergence of waves that lead to ovulation.
Blood samples were collected before (basal) and after (at the
expected peak time point as seen from pre-pubertal data) the
drug administration. Following the administration of kisspeptin
or buserelin, the animals were examined daily for 25 days using
ultrasound for follicular dynamics.

kisspeptin/buserelin are: 30 min, 1, 2, 3, and 4 h. The same for IV
kisspeptin/buserelin are: 15, 30 min, 1, 1.5, and 2 h. The delay in
collecting blood samples, if any, was never more than 2 min of
the prescribed time point. Blood samples, collected separately in
heparinized vials and serum tubes, were kept on ice until reaching
the lab; plasma and serum were separated and stored at −20◦ C
until LH and FSH levels were analyzed using bovine ELISA kits
(Abnova).

Effect of Two Different Protocols Involving Kisspeptin
or Buserelin on Follicular Dynamics During Oestrus
Synchronization

Effect of Repeated Injections of Kisspeptin on
Plasma LH and FSH
In order to mimic a long-acting agonist or a sustained release
system, and to study whether GPR54 is desensitized upon
multiple injections of kisspeptin, the drug was administered IV
at 10 µg/kg at 30 min intervals for five times and the levels of
FSH and LH were studied. Three pre-pubertal buffaloes, in which
LH response to kisspeptin was consistent with dose and was the
highest, were chosen for this study.

Two months after studying the effect of drugs on follicular
dynamics, the efficacy of kisspeptin on synchronization of
oestrus in buffaloes was studied in comparison with buserelin.
The buffaloes treated with buserelin in the earlier study were
subjected to Ovsynch protocol that involved administration
of buserelin (10 µg, IV) on day 0, followed by PGF2α (500
µg Cloprostenol sodium, Vetmate, Vet Care) on day 7 and a
second injection of buserelin (10 µg, IV) on day 9 (Figure 2).
The buffaloes treated with kisspeptin in the earlier study were
administered kisspeptin (20 µg/kg, IV) following the same
protocol. The first dose was administered on a day that was
randomly chosen. Fixed-time artificial inseminations (FTAI)
were done in both the groups 18-24 h after the administration of
second dose of kisspeptin or buserelin. Ovarian ultrasonography
was carried out daily from the day of initiation of the
synchronization protocol until insemination to study the time of
wave emergence after first dose of the drug, number of follicles
at wave emergence, diameter of the dominant follicle after the
administration of first and second dose of kisspeptin or buserelin.
Oestrus response rate and duration of oestrus were recorded
by visual inspection. First service conception was recorded by
diagnosing pregnancy by trans-rectal examination on day 45.

Follicular Dynamics
The pre-pubertal buffalo heifers were monitored for their ovarian
follicular growth and ovulation, if any, on every alternate day
by ultrasound examination using a real-time B mode ultrasound
machine (Aloka ProSound 2, Hitachi) equipped with a 5–7.5
MHz linear array transducer designed for per-rectal examination.
The transducer was placed on the ovary through rectal wall and
scanning was accomplished in several planes to identify follicles.
The desired images were frozen on the screen and measurements
were taken using an inbuilt calibration system. The number and
size of the follicles were recorded. The growth of individual
follicles was tracked with ultrasound examination every other
day. Average number of follicles per wave was calculated by
summing up the follicular count for each day of the wave and
dividing by the duration of the wave. Total number of follicles
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Statistics

undertaken. GraphPad Prism (Version 6.07, GraphPad Software
Inc.) statistical software was used to analyze endocrine profile
data using two-way repeated measures analysis of variance (RM
ANOVA) followed by Dunnett’s or Sidak’s multiple comparison
tests. SPSS (Version 16.0, SPSS Inc) statistical software was
used to analyze follicular dynamics data using t-test or ANOVA
followed by Duncan’s multiple range test. Differences were
considered to be significant when P < 0.05.

Data were compiled using Excel (Microsoft Inc) and given as
mean ± SEM.Tthe data were normally distributed and variances
were homogeneous; no manipulations or transformations were

RESULTS
Dose-Response Study in Pre-pubertal
Buffaloes
Kisspeptin (IM and IV) dose-dependently elevated plasma LH
levels in pre-pubertal buffaloes (IM: kisspeptin 5 vs. 20 µg/kg
at 30 min, P < 0.05; IV: kisspeptin 5 vs. 10 and 20 µg/kg at
15 min, P < 0.05; two-way RM ANOVA, followed by multiple
comparison tests; Figures 3A,B). The peak values were observed
at 15 and 30 min time points for IV and IM injections,
respectively. However, the LH level reached basal values by 2 h.
Upon administration of buserelin (IM and IV), there was a
gradual and sustained release of LH (IM: Basal vs. 2, 3, and 4 h

FIGURE 2 | Schematic representation of Ovsynch protocols tested in Murrah
buffaloes for oestrus synchronization using either buserelin or kisspeptin. On
day 0 and 9, animals in buserelin group were treated with buserelin (10
µg/animal, IV) while that in kisspeptin group received kisspeptin (20 µg/kg, IV).
PGF2α (500 µg, IV) was administered on day 7. Fixed time AI was done
18–24 h post second dose of buserelin or kisspeptin.

FIGURE 3 | Effect of kisspeptin or buserelin on plasma LH and FSH levels in pre-pubertal buffaloes out of the breeding season. (A) Kisspeptin IM dose-dependently
elevated plasma LH levels in pre-pubertal buffaloes. However, the LH level reached basal values by 2 h. Buserelin resulted in a gradual but sustained increase in LH
level (*kisspeptin 20 µg/kg: basal vs. at 30 min; kisspeptin: 5 vs. 20 µg/kg at 30 min; φbuserelin: basal vs. at 2, 3, and 4 h; buserelin vs. all kisspeptin groups at 2, 3,
and 4 h time points; P < 0.05, RM ANOVA followed by Dunnett’s multiple comparison test). (B) The release kinetics of LH upon IV injections of the drugs were similar
to that of IM injections of drugs. (*buserelin: basal vs. at 15 min; kisspeptin: basal vs. kisspeptin 10 and 20 µg/kg at 15 min; 9kisspeptin 20 µg/kg: basal vs. at 30 min;
φbuserelin: basal vs. at 1, 1.5, and 2 h; buserelin vs. kisspeptin 5 and 10 µg/kg at 1 h; buserelin vs. kisspeptin 5, 10, and 20 µg/kg at 1.5 and 2 h; P < 0.05, RM
ANOVA followed by Dunnett’s multiple comparison test). (C) There was no significant increase in plasma FSH upon IM injections of both drugs. (D) Buserelin
significantly elevated plasma FSH at 1.5 and 2 h post-injection, however, it was not significantly different from kisspeptin group (*buserelin: basal vs. at 1.5 and 2 h;
P < 0.05, RM ANOVA followed by Dunnett’s multiple comparison test). Data represented as mean ± SEM (n = 5–6 animals at each time point).
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the growth rate of the follicles compared to all other doses of
kisspeptin and of buserelin (P < 0.05, one-way ANOVA followed
by Duncan multiple range test). The maximum diameter of
dominant follicle was not different among the groups. The results
are summarized in Table 1.

post-drug, P < 0.05; IV: Basal vs. 1, 1.5, and 2 h post-drug, P
< 0.05; two-way RM ANOVA, followed by multiple comparison
tests; Figures 3A,B). While IM administration of kisspeptin (20
µg/kg) maximally elevated the LH concentration only to 7.29
± 1.7 ng/ml (at 30 min), IV injection elevated the same to 17.4
± 4.4 ng/ml (at 15 min; P = 0.04, t-test). Though IV injection
of buserelin increased the LH concentration at 2 h post-drug
to 30.79 ± 11.47 ng/ml, it was not significantly higher than the
concentration at 2 h (17.81 ± 5.16 ng/ml) after IM injection. FSH
was not significantly elevated upon kisspeptin, while buserelin
IV increased FSH in a slow and sustained manner (IV: Basal
vs. at 1.5 and 2 h, P < 0.05, RM ANOVA followed by multiple
comparison tests; Figures 3C,D), similar to that of LH response.
The interaction between time and treatment was significant for
both routes of injections and for both FSH and LH (P < 0.001,
two-way RM ANOVA).

Effect of Repeated Administration of
Kisspeptin on Plasma LH and FSH
Repeated administration of kisspeptin (10 µg/kg, IV, a total of
five injections at 30 min intervals) elevated LH in a sustained
manner (Figure 4A). Compared to basal concentration,
the LH level remained significantly elevated until 30 min
after repeated kisspeptin (P < 0.05, one-way RM ANOVA
followed by Dunnett’s multiple comparison tests). After
increasing from basal level to 36.28 ± 8.66 ng/ml upon first
kisspeptin injection, the LH concentration reached 26.42
± 5.93 ng/ml upon second injection. However, compared
to basal concentration, LH level increased further upon
third and fourth injections to 32.32 ± 10.28 and 48.81
± 11.49 ng/ml, respectively. At 2.5 h, i.e., 30 min after
the fifth kisspeptin injection, LH concentration reached a
maximum of 57.15 ± 15.27 ng/ml, after which it started
declining. Though the FSH concentration followed a similar
pattern, it was not significant (Figure 4B). LH levels upon
repeated kisspeptin administration was comparable with the
response following buserelin (10 µg; IV) in terms of sustained
release of LH (Figure 4C). Though LH level upon repeatedkisspeptin remained elevated throughout the observation,
without being statistically significant, compared to that
upon single injection of buserelin, at 30 min, kisspeptininduced increase in LH concentration was significantly

Follicular Dynamics in Pre-pubertal
Buffaloes
We observed follicular wave pattern in pre-pubertal heifers with
each wave lasting for about 8–8.5 days, without any ovulation.
Emergence of a wave was observed when the dominant follicle
of the previous wave started to become atretic. The data were
combined for different doses and/or routes of the drugs as
and when there were no significant differences. The average
number of follicles in a wave and the number of follicles at wave
emergence were significantly more in buserelin group compared
to kisspeptin group and control (P < 0.05, one-way ANOVA
followed by Duncan multiple range test). Though the overall
growth rate of follicles was increased upon administration of
both the drugs, kisspeptin at 5 µg/kg, IM, significantly increased

TABLE 1 | Comparison of ovarian response to kisspeptin or buserelin in pre-pubertal buffaloes out of the breeding season.
S. No.

Parameters

Control (n = 11)

Kisspeptin (n = 6)

Buserelin (n = 5)

1.

Length of wave (d)

8.2 ± 0.4

8.0 ± 0.4

8.5 ± 0.5

2.

Average number of follicles per wave

3.49 ± 0.09b

3.46 ± 0.05b

4.12 ± 0.06a

Small follicles (<5 mm)

1.89 ± 0.08b

1.81 ± 0.05b

2.13 ± 0.06a

Medium Follicle (5–8 mm)

1.39 ± 0.05b

1.60 ± 0.03a

1.63 ± 0.03a

Large follicles (>8 mm)

1.06 ± 0.03a

1.59 ± 0.03b

1.18 ± 0.02a

No. of follicles at wave emergence

4.57 ± 0.20b

4.67 ± 0.10b

5.90 ± 0.11a

Growth rate of follicle (mm/d): Overall (doses and routes combined)

0.37 ± 0.04a

0.66 ± 0.05b

0.59 ± 0.10b

0.80 ± 0.17c

0.57 ± 0.19b

3.
4.
5.

Effect of IM administration of drugs on follicular growth rate (mm/d)
0.37 ± 0.04a

5 µg/kg BW

6.

10 µg/kg BW

0.57 ± 0.09b

20 µg/kg BW

0.67 ± 0.08b

Effect of IV administration of drugs follicular growth rate (mm/d)
0.60 ± 0.13b

5 µg/kg BW
10 µg/kg BW

0.37 ± 0.04

0.70 ± 0.19b

20 µg/kg BW
7.

0.6 ± 0.13b

0.65 ± 0.15b

Maximum diameter of dominant follicle (mm)

10.5 ± 0.48

10.81 ± 0.19

10.76 ± 0.25

Kisspeptin was administered at three different doses (5, 10, and 20 µg/kg) at two routes (i.e., IM or IV) at weekly intervals approximately. A minimum of 4 ultrasound observations of
follicular dynamics were carried out on alternate days between two injections. Buserelin was administered at a single dose rate (10 µg/animal) recommended by the manufacturer via
two routes (i.e., IM or IV) at triweekly intervals approximately. Follicular growth rate was the greatest when kisspeptin was administered at 5 µg/kg, IM. Numerical values with different
superscripts within the rows are significantly different. One way ANOVA followed by Duncan’s multiple range test (p < 0.05).
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FIGURE 4 | Effect of repeated administration of kisspeptin on plasma LH and FSH. (A) Repeated administration of kisspeptin (10 µg/kg) elevated LH in a sustained
manner (*vs. basal; P < 0.05, one-way RM ANOVA). (B) There was no significant increase in FSH level upon repeated administration of kisspeptin. (C) LH levels upon
repeated kisspeptin administration were higher than that upon a single injection of buserelin (*kisspeptin: basal vs. all time points; φ buserelin: basal vs. 1.5 and 2 h; 9
buserelin vs. kisspeptin at 30 min; RM ANOVA followed by Dunnett’s and Sidak’s multiple comparison test). Data represented as mean ± SEM (n = 3–5 animals at
each time point).

Effect of Kisspeptin vs. Buserelin on
Follicular Dynamics in Adult Buffaloes

higher than buserelin-induced LH (P < 0.05, two-way RM
ANOVA followed by Dunnett’s multiple comparison tests).
However, there was no interaction between time and treatments
(P > 0.05, two-way RM ANOVA).

There was no significant difference in the length of the oestrous
cycle between kisspeptin- and buserelin-treated groups. The
number of follicles at wave emergence was significantly more in
kisspeptin-treated group (12.16 ± 0.47) compared to buserelintreated group (10.33 ± 0.42; P < 0.05, t-test). The average
number of follicles in the wave was also significantly higher in
kisspeptin-treated group (9.33 ± 0.49) than in buserelin-treated
group (7.16 ± 0.30; p < 0.05, t-test). There was no significant
difference between the groups in maximum diameter as well as
growth rate of dominant and subordinate follicles. However, the
diameter of ovulatory follicle was larger (13.83 ± 0.47 mm) in
kisspeptin group compared to buserelin group (11.00 ± 0.36 mm;
P < 0.05, t-test). The results are summarized in Table 2.

Effect of Kisspeptin vs. Buserelin on
Plasma LH and FSH in Adult Buffaloes
Experimental buffaloes that received either kisspeptin (20 µg/kg,
IV) or buserelin (10 µg, IV) on 11th or 8th day of estrous
cycle, i.e., in correlation with emergence of waves, depending
on whether the oestrous cycle is of two-wave or three-wave
pattern, respectively, were sampled before (basal) and after
(at the peak time point as seen from pre-pubertal data:
at 15 min after kisspeptin and at 2 h after buserelin) drug
administration. While both the drugs increased plasma LH
levels (P < 0.05, t-test), the increase was significantly more in
buserelin group compared to kisspeptin group (P = 0.02, ttest; Figure 5A). In addition, while kisspeptin did not increase
plasma FSH concentration compared to basal level, buserelin
significantly increased FSH concentration (P < 0.05, t-test;
Figure 5B).
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Follicular Dynamics During Oestrus
Synchronization
All the animals had at least one follicle of more than 10 mm
diameter at the time of administration of 1st dose of drugs. The
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TABLE 2 | Effect of kisspeptin and buserelin on follicular dynamics in adult Murrah
buffaloes.
S. No.

Parameters

Kisspeptin
(n = 6)

Buserelin
(n = 6)

1.

Length of oestrous cycle (days)

22.66 ± 0.42

24.16 ± 0.30

2.

Number of follicles at wave
emergence after drug administration

12.16 ± 0.47*

10.33 ± 0.42

3.

Total number of follicles

9.33 ± 0.49*

7.16 ± 0.30

4.

Growth rate of the dominant follicle
(mm/day)

1.66 ± 0.18

1.31 ± 0.08

5.

Growth rate of the subordinate follicle
(mm/day)

1.16 ± 0.14

0.8 ± 0.10

6.

Maximum diameter of ovulatory
follicle (mm)

7.

Maximum diameter of subordinate
follicle (mm)

13.83 ± 0.47*

11.00 ± 0.36

9.23 ± 0.08

8.33 ± 0.33

Experimental buffaloes that received either kisspeptin (20 µg/kg body weight, IV) or
buserelin (10 µg/animal, IV) on 11th or 8th day of estrous cycle (i.e., correlating with
emergence of waves depending on whether the oestrous cycle is of two-wave or
three-wave pattern, respectively) were observed for follicular dynamics using ultrasound
examination on alternate days. Kisspeptin administration significantly increased the
number of follicles at wave emergence, total number of follicles and diameter of ovulatory
follicle. Data represented as mean ± SEM. *P < 0.05, t-test.

FIGURE 5 | Alteration in the plasma LH and FSH levels in adult Murrah
buffaloes by buserelin and kisspeptin. Experimental buffaloes that received
either kisspeptin (20 µg/kg body weight, IV) or buserelin (10 µg/animal, IV) on
11th or 8th day of estrous cycle (i.e., correlating with emergence of waves
depending on whether the oestrous cycle is of two-wave or three-wave
pattern, respectively) were sampled before (basal) and after drug
administration (post-drug samples were collected at the peak time-point as
observed in pre-pubertal animals: at 15 min after kisspeptin and at 2 h after
buserelin). (A) While both the drugs increased plasma LH levels (*P < 0.05,
t-test), the increase was significantly more in buserelin group (n = 6) compared
to kisspeptin group (n = 6) (# P = 0.02, t-test). (B) Buserelin significantly
increased FSH concentration while kisspeptin did not (*, # P < 0.05, t-test).
Data represented as mean ± SEM.

LH, the release was short-lived and was smaller compared to
buserelin-induced LH release. This pattern of immediate release
of LH and ensuing declination after the initial rise have been
observed earlier with kisspeptin administration (10). While
buserelin sustained the FSH release, kisspeptin had little effect
on plasma FSH. Less significant FSH release, as compared to
LH release, upon kisspeptin administration has been reported
earlier in cattle, pigs and mice (8, 11, 12). FSH release is not fully
controlled by GnRH as ovarian factors like activin and inhibin are
also involved in FSH regulation (13, 14). Hence, high FSH levels
for several hours upon peripheral administration of kisspeptin
observed elsewhere in ovariectomized oestradiol treated ewes
may be due to lack of inhibin upon ovariectomy (10).
Both IV and IM injections of kisspeptin were similar in
terms of duration of LH increase, however, IV injection resulted
in an earlier increase and a higher LH concentration than
the IM injection. This important finding may be of significant
commercial and clinical importance. The peak LH values were
similar with both 10 and 20 µg/kg dose rates of kisspeptin, IV.
Hence, we chose to inject kisspeptin at the smallest dose tested
that gives near-maximal response, i.e., 10 µg/kg, IV, repeatedly, so
as to simulate injecting a long-acting form of kisspeptin and study
the LH release response. Interestingly, LH response to repeated
injections of kisspeptin were similar to the response observed
upon single injection of buserelin, a long-acting GnRH agonist,
however, there was no evidence of additive effect. A single dose
of kisspeptin inducing a short-lived stimulation of LH release
and repeated intravenous administration of kisspeptin inducing
a sustained train of FSH and LH pulses were reported earlier in
livestock (10, 15). Lack of additive effect upon repeated kisspeptin
has been shown earlier in pre-pubertal ewes (16). Pulsatile
administration of kisspeptin once every hour for 24 h has

proportion of animals that ovulated after 1st dose of drug (33.33
vs. 16.66%), the proportion of animals that showed onset of a new
follicular wave (100 vs. 83.33%), the oestrous response rate (83.33
vs. 66.66%) and conception rate (66.66 vs. 50%) in kisspeptinPGF2α -kisspeptin group vs. buserelin-PGF2α -buserelin group
were statistically insignificant (P > 0.05, Fisher’s exact test). The
number of follicles at wave emergence was significantly higher
in kisspeptin group (11.00 ± 0.51) than in buserelin group (8.33
± 0.49; P < 0.05, t-test). In addition, the mean diameter of
ovulatory follicle after 2nd dose of drug was also significantly
higher in kisspeptin group (15.58 ± 0.42 mm) compared to
buserelin group (13.6 ± 0.47 mm; P < 0.05, t-test). Further, the
duration of oestrus was also higher in kisspeptin group than in
buserelin group (22.5 ± 1.4 h vs. 18.16 ± 1.01 h; P < 0.05, t-test).
Follicular dynamics observed during oestrous synchronization in
buffaloes with kisspeptin or buserelin is shown in Table 3.

DISCUSSION
Buserelin, as expected, resulted in a robust and sustained release
of LH. Though kisspeptin dose-dependently increased plasma
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behind differential regulation of follicular dynamics by kisspeptin
and buserelin remains unexplored.
Our further studies on gonadotropin and follicular responses
upon kisspeptin and buserelin administration in adult buffaloes
were carried out when the drugs were administered at the
beginning of the last follicular wave of oestrous cycle that leads
to ovulation. In adult buffaloes, similar to pre-pubertal heifers,
buserelin-induced LH response was many folds higher compared
to kisspeptin-induced response. However, in contrast to heifers,
average number of follicles in a wave and number of follicles
at wave emergence were higher in kisspeptin group compared
to buserelin group. The diameter of the ovulatory follicle was
also larger in kisspeptin group. This was observed again in the
adult buffaloes when the drugs were administered randomly
for oestrous synchronization. This suggests that differential
regulation of follicular dynamics kisspeptin and GnRH may
further differ depending on the cyclicity or reproductive
age of the animals. Differential LH responses to kisspeptin
administration at different time points within oestrous cycle
have been reported earlier in ewes (24). However, ours is the
first study to report such responses among different age-groups.
Age-dependent variation in the responses might possibly be due
to differences in the maturation of the reproductive axis and
neuroendocrine signaling, oestrous cycle, body weight, etc. (25).
Elucidating the mechanism behind this variation was beyond the
scope of our study.
Though we observed promising results with kisspeptin when
we used it for oestrous synchronization, unless the studies
are repeated in a large number of animals, we may not be
able to confirm the results. As pregnancy rate is the ultimate
parameter to assess the success of a synchronization protocol,
the study has to be carried out in a larger herd to arrive at a
conclusion. However, ovulatory rates of more than 80% induced
by kisspeptin, a short-acting peptide, similar to that induced by
buserelin, a long-acting GnRH agonist, is intriguing. Kisspeptin
treatment resulting in ovulation has been reported earlier in ewes
and cows (10, 23). However, our study is the first one to report
the same in comparison with a routinely used GnRH agonist.
Though this study is of important clinical relevance, the
study limitations, such as wide variation in the age of adult
experimental buffaloes used, seasonal variation in hormonal
levels (i.e., pre-pubertal buffaloes were studied during summer
while adult buffaloes were studied during fall and winter),
and usage of bovine ELISA kits for analyzing LH and FSH
concentration in plasma samples of experimental buffaloes, are to
be acknowledged and accordingly, the results may be cautiously
interpreted.
Whether kisspeptin can be administered at larger dose rates,
i.e., more than 20 µg/kg, the maximal dose used in our study,
so as to enhance the LH response, needs to be tested further.
Optimization of the effective dose based on LH release and
on follicular dynamics will help us to formulate an oestrus
synchronization regimen that can be used as a treatment strategy
for repeat breeders and also as a management strategy for embryo
collection and transfer in embryo biotechnology. This will also
help us to develop a kisspeptin-based protocol to induce oestrus
and ovulation in pre-pubertal and anoestrus animals.

TABLE 3 | Follicular dynamics during oestrus synchronization: Effect of two
different protocols involving kisspeptin or buserelin.
S. No.

Parameters

Kisspeptin
(n = 6)

Buserelin
(n = 6)

1.

Proportion of animals that ovulated
after first dose

33.33 (2/6)

16.66 (1/6)

2.

Proportion of animals that started
new follicular wave after first dose

100 (6/6)

83.33(5/6)

3.

Time of emergence of new follicular
wave since drug (h)

52.00 ± 1.31

50.5 ± 1.1

4.

Number of follicles at wave
emergence

11.00 ± 0.51*

8.33 ± 0.49

5.

Maximum diameter of ovulatory
follicle after second dose

15.58 ± 0.42*

13.6 ± 0.47

6.

Proportion of animals that ovulated
after second dose

83.33 (5/6)

83.33 (5/6)

7

Oestrous response

83.33(5/6)

66.66 (3/6)

8.

Duration of oestrus (h)

22.5 ± 1.4*

18.16 ± 1.01

9.

Conception rate on day 45 since
FTAI (%)

66.66 (4/6)

50.00 (3/6)

Ovarian ultrasonography was carried out daily from the day of initiation of the
synchronization protocol, using either kisspeptin or buserelin, until insemination. Number
of follicles at wave emergence, maximum diameter of ovulatory follicle and duration of
oestrus were greater in kisspeptin group. Data represented as mean ± SEM. *P < 0.05,
t-test.

been reported to enhance gonadotropin secretion and ovarian
steroidogenesis and to stimulate LH surge and ovulation (17).
However, we did not study the follicular dynamics upon repeated
kisspeptin administration.
Continuous infusion of human metastin 45–54 has been
shown to desensitize GPR54 in agonadal juvenile male rhesus
monkeys (18). Once-daily subcutaneous injection as well as
continuous administration of kisspeptin analogs, TAK-448 and
TAK-683, suppressed the pituitary-gonadal functions in male rats
as evidenced by reduction in testosterone levels (19). On the
contrary, the unstinted LH response upon repeated kisspeptin,
observed in our study, suggests lack of receptor desensitization.
It has been observed that the peak LH level in buffaloes during LH
surge is 20-40 ng/ml and the surge lasts for 7–12 h (20). Though
similar LH levels are reached with kisspeptin in our study, the
duration of release is less compared to endogenous LH surge
requiring further studies on receptor desensitization in buffaloes.
In pre-pubertal buffaloes, we observed that the number of
follicles were significantly more in buserelin group, while the size
of follicles was larger in kisspeptin group. Hence, it appears that
kisspeptin and buserelin differentially govern follicular dynamics.
Presence of kisspeptin and GnRH receptors have been shown
in the ovarian cells (4, 21, 22). Hence, systemic injections of
these drugs possibly act via local ovarian mechanisms, in addition
to the effects via release of gonadotropins that act on ovarian
cells. Buserelin-induced increase in FSH may have contributed
for greater increase in number of follicles in buserelin group.
An earlier report of effect of kisspeptin on follicular dynamics
observed that kisspeptin-53 at 2 nmol/kg increased the size of
dominant follicle in cattle (23). However, no effects on number
of follicles were observed or reported so far and, the mechanism
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Novel therapeutic strategies are warranted for treating
reproductive disorders in farm animals. This project, aiming at
studying the effect of kisspeptin on plasma endocrine profile
and follicular dynamics, enables us to compute kisspeptinbased treatment strategies for fertility disorders in livestock.
This study supplements the potential applications of kisspeptin
in reproductive management of farm animals that has been
thoroughly reviewed Caraty et al. (26).
In conclusion, this study finds that IV administration of
kisspeptin might be more beneficial in terms of LH release
rather than IM. It also observes that kisspeptin and GnRH
may differentially regulate follicular dynamics depending on
reproductive age of the animals. The mechanism for this
differential regulation needs to be explored. A novel protocol
using kisspeptin for oestrus synchronization tested in adult
cycling buffaloes demonstrated beneficial effects, however, a
larger sample size is required to further confirm the results.
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